Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:47 PM
Ignite Modification Date:
2025-12-24 @ 10:47 PM
NCT ID:
NCT06405269
Eligibility Criteria:
Inclusion Criteria:
* ECOG score 0-1
* Resectable breast cancer
* No distant metastases on postoperative imaging assessment
* Patients proposed for (neo)adjuvant therapy
* No previous oral lipid-lowering drugs, serum LDL-C level within normal range, i.e. LDL-C value: \<3.4 mmol/L
* No fatty liver by liver ultrasound/CT examination
* No major organ dysfunction
Exclusion Criteria:
* Patients with pre-existing hyperlipidaemia, coronary heart disease, fatty liver disease, or who have received or are receiving lipid-lowering medication
* Enrolled in another study or less than or equal to 4 weeks since discontinuation of other medications
* Presence of severe dysfunction of vital organs
* Patients with other malignancies (except cured non-melanoma skin cancer, cervical carcinoma in situ and other tumours that have been cured for at least 5 years)
* Acute infectious diseases or chronic infectious diseases in active stage
* History of uncontrolled epilepsy, central nervous system disease or mental disorder
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT06405269
Study Brief:
Protocol Section:
NCT06405269